Ophthalmology Times Europe parent company MJH Life Sciences® acquires eye care conference EnVision Summit

News
Article

The Eye Care Network adds a longstanding, CME-certified conference to its live event programming

An aerial view of San Juan, Puerto Rico. Image credit: ©Jacob – stock.adobe.com

The upcoming EnVision Summit is scheduled for 14-17 February, 2025, at the Caribe Hilton, San Juan, Puerto Rico. Image credit: ©Jacob – stock.adobe.com

Ophthalmology Times Europe is proud to report that MJH Life Sciences® has announced its acquisition of the EnVision Summit, a premier certified continuing medical education (CME) ophthalmology conference. The EnVision Summit, held annually in Puerto Rico, combines an innovative CME-certified education programme with a first-class family experience.

The summit will be hosted as a CME-certified conference within the Physicians’ Education Resource® legacy portfolio, supported by the eye care network brands Ophthalmology Times and Optometry Times. MJH Life Sciences noted in a press release that the acquisition aligns with its long-term growth strategy supported by a strategic partnership with BDT & MSD Partners.

The holistic approach to the summit includes age-appropriate activities for participants' family members, including children. In 2024, the EnVision Summit debuted an optometry track concurrent with the existing ophthalmology sessions.

Bonnie An Henderson, MD, the EnVision Summit director and cofounder, expressed enthusiasm about the future of the summit under MJH Life Sciences’ leadership. Dr Henderson President and CEO of global nonprofit HelpMeSee, as well as a past president of the American Society of Cataract and Refractive Surgery.

“I am thrilled about the possibilities that this acquisition brings for the EnVision Summit,” Dr Henderson said. “With the resources and expertise of MJH Life Sciences, we will be able to elevate our educational offerings to new heights, ensuring that eye care professionals worldwide have access to the most current and comprehensive information in multiple channels to better serve their patients. I look forward to continuing as the Programme Director to maintain the excellence of the content and faculty.”

Mike Hennessy Jr., president and CEO of MJH Life Sciences, commented on the news, describing it as a continuation of MJH Life Sciences’ mission. “As we continue to expand our commitment to education in the eye care space, the acquisition of EnVision Summit allows us to build on the strong foundation we’ve established with our leading brands,” he said. “The summit and its hundreds of loyal attendees will benefit not only from our expertise in providing engaging educational experiences on cutting-edge topics, but also from new and expanded opportunities to help them address the rapidly evolving ophthalmic landscape.”

The upcoming EnVision Summit is scheduled for 14-17 February, 2025, at the Caribe Hilton, San Juan, Puerto Rico.

To learn more and to register for the event, please visit www.envisionsummit.org.

Reference

1. MJH Life Sciences® acquires EnVision Summit, expands leadership in eye care education. MJH Life Sciences. Press release. Accessed 9 October, 2024.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.